 | This articlerelies largely or entirely on asingle source. Relevant discussion may be found on thetalk page. Please helpimprove this article byintroducing citations to additional sources. Find sources: "EA-2012" – news ·newspapers ·books ·scholar ·JSTOR(September 2018) |
 | |
| Names | |
|---|---|
| Preferred IUPAC name Bis(tetraphenylboranuide)N,N,N-trimethyl-3-({[(propan-2-yl)oxy](methylphosphonoyl)}oxy)-5-{4-[3-(trimethylazaniumyl)phenoxy]butoxy}anilinium | |
| Identifiers | |
3D model (JSmol) | |
| |
| |
| Properties | |
| C74H83B2N2O5P | |
| Molar mass | 1133.08 g·mol−1 |
| Appearance | Solid |
| Melting point | 171–172 °C (340–342 °F; 444–445 K) |
| Insoluble | |
| Solubility | Soluble in acetone |
| Hazards | |
| Occupational safety and health (OHS/OSH): | |
Main hazards | Extremely toxic |
| Lethal dose or concentration (LD, LC): | |
LD50 (median dose) | 93 μg/kg (Rats, IV) 17 μg/kg (Rabbits, IV) |
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa). | |
EA-2012 is an extremely toxicorganophosphatenerve agent. It is an extremely potentacetylcholinesterase inhibitor that is resistant toatropine and oxime treatment.[1]
